The Impact of Benign Gene Expression Classifier Test Results on the Endocrinologist–Patient Decision to Operate on Patients with Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytopathology
Thyroid2012Vol. 22(10), pp. 996–1001
Citations Over TimeTop 10% of 2012 papers
Daniel S. Duick, Joshua Klopper, James Diggans, Lyssa Friedman, Giulia C. Kennedy, Richard B. Lanman, Bryan McIver
Abstract
In a substantial group of medical practices, obtaining an AGEC test in patients with cytologically indeterminate nodules was associated with a striking reduction in the rate of diagnostic thyroidectomy. Approximately, one surgery was avoided for every two AGEC tests run on thyroid FNAs with indeterminate cytology.
Related Papers
- → Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology(2012)1,154 cited
- → Indeterminate thyroid nodules in the era of molecular genomics(2020)23 cited
- → Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing(2019)15 cited
- → Role of Molecular Diagnostic Markers in the Management of Indeterminate and Suspicious Thyroid Nodules(2014)4 cited
- → Economic Impact of a Novel Molecular Diagnostic Test in Evaluation of Thyroid Nodules with Indeterminate FNA Cytology Results.(2010)2 cited